ES8702945A1 - Un metodo de producir activador de plasminogeno de tejido uterino humano - Google Patents

Un metodo de producir activador de plasminogeno de tejido uterino humano

Info

Publication number
ES8702945A1
ES8702945A1 ES547416A ES547416A ES8702945A1 ES 8702945 A1 ES8702945 A1 ES 8702945A1 ES 547416 A ES547416 A ES 547416A ES 547416 A ES547416 A ES 547416A ES 8702945 A1 ES8702945 A1 ES 8702945A1
Authority
ES
Spain
Prior art keywords
products
recombinant dna
dna techniques
sequence encoding
cdna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547416A
Other languages
English (en)
Other versions
ES547416A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Integrated Genetics Inc
Original Assignee
Integrated Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrated Genetics Inc filed Critical Integrated Genetics Inc
Publication of ES8702945A1 publication Critical patent/ES8702945A1/es
Publication of ES547416A0 publication Critical patent/ES547416A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2795/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/70—Vector systems having a special element relevant for transcription from fungi
    • C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Abstract

METODO DE PRODUCCION DE ACTIVADORES DE PLASMINOGENO DE TEJIDO UTERINO HUMANO. CONSISTE EN LA TRANSFORMACION DE CELULAS HOSPEDADORAS, TAL COMO LEVADURAS O CELULAS DE MAMIFERO; CULTIVO DE LAS CELULAS TRANSFORMADAS CON UN VECTOR DE EXPRESION REPLICABLE QUE TIENE UNA SECUENCIA DE ADN QUE CODIFICA ACTIVADOR DE PLASMINOGENO DE TEJIDO UTERINO HUMANO ACTIVO, Y ES CAPAZ DE EXPRESAR DICHA SECUENCIA EN LA CELULA HOSPEDADORA TRANSFORMADA; EXTRACCION DE DICHO ACTIVADOR DEL MEDIO DE CULTIVO Y PURIFICACION MEDIANTE METODOS CONVENCIONALES. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA DISOLVER COAGULOS EN PACIENTES CON ENFERMEDADES VASCULARES.
ES547416A 1984-10-01 1985-09-30 Un metodo de producir activador de plasminogeno de tejido uterino humano Expired ES8702945A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65677084A 1984-10-01 1984-10-01

Publications (2)

Publication Number Publication Date
ES8702945A1 true ES8702945A1 (es) 1987-01-16
ES547416A0 ES547416A0 (es) 1987-01-16

Family

ID=24634490

Family Applications (3)

Application Number Title Priority Date Filing Date
ES547416A Expired ES8702945A1 (es) 1984-10-01 1985-09-30 Un metodo de producir activador de plasminogeno de tejido uterino humano
ES554449A Expired ES8706726A1 (es) 1984-10-01 1986-04-28 Un metodo de purificar activador de plasminogeno de tejido uterino
ES554450A Expired ES8801306A1 (es) 1984-10-01 1986-04-28 Un metodo de purificar activador de plasminogeno de tejido humano

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES554449A Expired ES8706726A1 (es) 1984-10-01 1986-04-28 Un metodo de purificar activador de plasminogeno de tejido uterino
ES554450A Expired ES8801306A1 (es) 1984-10-01 1986-04-28 Un metodo de purificar activador de plasminogeno de tejido humano

Country Status (14)

Country Link
US (1) US5344773A (es)
EP (1) EP0178105B1 (es)
JP (1) JPS61149094A (es)
AT (1) ATE151111T1 (es)
AU (1) AU599576B2 (es)
DE (1) DE3588149T2 (es)
DK (1) DK175327B1 (es)
ES (3) ES8702945A1 (es)
FI (1) FI89723C (es)
IE (1) IE81135B1 (es)
NO (1) NO175158C (es)
NZ (1) NZ213647A (es)
PT (1) PT81231B (es)
ZA (1) ZA857574B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479520D1 (en) * 1983-11-21 1989-09-28 Ciba Geigy Ag Synthesis of tissue plasminogen activator(tpa) by yeast
US5073494A (en) * 1985-04-22 1991-12-17 Genentech, Inc. Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
JP2581668B2 (ja) * 1985-11-27 1997-02-12 三井東圧化学株式会社 ヒト正常細胞由来のヒト組織プラスミノ−ゲン活性化因子をコ−ドする新しいｄｎａ配列とそれを含むベクタ−及び細胞
DE3684680D1 (de) * 1985-12-23 1992-05-07 Chiron Corp Peptidplasminogenaktivatoren.
US5837518A (en) * 1986-01-31 1998-11-17 Genetics Institute, Inc. Thrombolytic proteins
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins
US5258298A (en) * 1986-01-31 1993-11-02 Genetics Institute, Inc. Deletion and glycosylation mutant of human tissue plasminogen activator
US5589361A (en) * 1986-03-18 1996-12-31 Genentech, Inc. Human tissue-type plasminogen activator variant
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
DE122007000007I1 (de) 1986-04-09 2007-05-16 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US5047241A (en) * 1986-07-11 1991-09-10 American Home Products Corporation Tris-Kringle plasminogen activator with novel K2 insert
WO1988000615A1 (en) * 1986-07-16 1988-01-28 Celltech Limited Process for purifying a plasminogen activator
US5580559A (en) * 1986-12-05 1996-12-03 Ciba-Geigy Corporation Hybrid plasminogen activator
US5242819A (en) * 1986-12-05 1993-09-07 Ciba-Geigy Corporation DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
WO1988005822A1 (en) * 1987-01-30 1988-08-11 American Home Products Corporation Des-epidermal growth factor plasminogen activators
JPH084501B2 (ja) * 1987-03-20 1996-01-24 エーザイ株式会社 糖鎖に関する変異ｔＰＡ
EP0292009A1 (en) * 1987-05-22 1988-11-23 Zymogenetics, Inc. Fibrinolytic proteins
AU1668988A (en) * 1987-06-03 1988-12-08 Smithkline Beckman Corporation Purification of tpa
US6682733B1 (en) * 1987-06-18 2004-01-27 Roche Diagnostics, Gmbh Fibrinolytic enzymes
DE3726019A1 (de) * 1987-08-05 1989-02-16 Boehringer Mannheim Gmbh Verfahren zur abtrennung und reinigung von t-pa
US5244676A (en) * 1987-10-09 1993-09-14 Monsanto Company Modified tissue plasminogen activator with modified glycosylation site
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
US5100666A (en) * 1987-10-09 1992-03-31 Monsanto Company Modified tissue plasminogen activator K2K2SP
US5037752A (en) * 1987-10-09 1991-08-06 Monsanto Company Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5665583A (en) * 1988-08-12 1997-09-09 Arch Dev Corp Methods and materials relating to IMPDH and GMP production
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5070021A (en) * 1989-01-10 1991-12-03 Monsanto Company Method of modifying oligosaccharide structure of tissue plasminogen activator
US5268273A (en) * 1990-12-14 1993-12-07 Phillips Petroleum Company Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same
DK0643772T3 (da) * 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
US7299805B2 (en) 2002-06-07 2007-11-27 Marctec, Llc Scaffold and method for implanting cells
WO2014116706A1 (en) * 2013-01-22 2014-07-31 University Of Tennessee Research Foundation Tissue plasminogen activator antibodies and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
ZA833174B (en) * 1982-05-05 1984-08-29 Genentech Inc Human tissue plasminogen activator
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
WO1984001786A1 (en) * 1982-10-28 1984-05-10 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
IE56716B1 (en) * 1983-01-19 1991-11-20 Genentech Inc Method for producing human tpa and expression vectors therefor
DE3479520D1 (en) * 1983-11-21 1989-09-28 Ciba Geigy Ag Synthesis of tissue plasminogen activator(tpa) by yeast
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
DE3684680D1 (de) * 1985-12-23 1992-05-07 Chiron Corp Peptidplasminogenaktivatoren.
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation

Also Published As

Publication number Publication date
NZ213647A (en) 1989-05-29
ATE151111T1 (de) 1997-04-15
ES8801306A1 (es) 1988-01-01
AU4814885A (en) 1986-04-10
FI853761L (fi) 1986-04-02
DK441585A (da) 1986-04-02
DK441585D0 (da) 1985-09-30
ZA857574B (en) 1986-06-25
US5344773A (en) 1994-09-06
FI89723C (fi) 1993-11-10
ES547416A0 (es) 1987-01-16
NO175158C (no) 1994-09-07
FI853761A0 (fi) 1985-09-30
EP0178105A2 (en) 1986-04-16
FI89723B (fi) 1993-07-30
PT81231B (pt) 1987-10-20
IE81135B1 (en) 2000-03-22
ES554449A0 (es) 1987-07-01
ES8706726A1 (es) 1987-07-01
EP0178105B1 (en) 1997-04-02
DE3588149T2 (de) 1997-10-09
DK175327B1 (da) 2004-08-23
ES554450A0 (es) 1988-01-01
AU599576B2 (en) 1990-07-26
EP0178105A3 (en) 1988-11-17
NO175158B (no) 1994-05-30
NO853851L (no) 1986-04-02
PT81231A (en) 1985-11-01
DE3588149D1 (de) 1997-05-07
JPS61149094A (ja) 1986-07-07
IE852394L (en) 1986-04-01

Similar Documents

Publication Publication Date Title
ES8801306A1 (es) Un metodo de purificar activador de plasminogeno de tejido humano
GB8508864D0 (en) Active polypeptide
EP0210461A3 (en) Physiologically active polypeptide buf-3
IL81839A0 (en) Polypeptide,dna and its use
EP0218717A4 (en) RECOMBINANT INHIBIN.
IL85372A0 (en) Peptides with laminin-like activity
DE3476761D1 (en) Unsaturated polyamidemacromeres, their preparation and their use
GB2203740B (en) Novel peptides, their preparation and use
DK224985A (da) Peptider, og midler indeholdende peptiderne
DE3581337D1 (en) Peptide.
DE3680838D1 (de) Stabilisierte menschliche prourokinase.
DE3886517T2 (de) Menschlicher Prourokinase ähnliches Polypeptid.
GB8430984D0 (en) Obstetrical chairs
EP0177583A4 (en) PEPTIDE VACCINE OR DIAGNOSTIC, AND POLYPEPTIDE FOR USE THEREOF.
EP0286114A3 (en) Reg gene and protein encoded by the gene
EP0189485A4 (de) Hexapeptid.
EP0280859A3 (en) Polypeptide having an antiviral activity, and its use
DE3686799D1 (en) Fuer dipterenlarven toxische polypeptide.
EP0199769A4 (en) NEW POLYPEPTIDES WITH GROWTH FACTOR EFFECT AND THESE ENCODING NUCLEIC ACID SEQUENCES.
EP0172233A4 (en) PUNAGLANDINS AND THEIR PHARMACEUTICAL USE.
ZA889506B (en) Soluble recombinant fce-receptor,the preparation and the use thereof
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same
ATE98990T1 (de) Menschlicher prourokinase aehnliches polypeptid.
IE870674L (en) Polypeptide, dna and its use
IE873131L (en) Recombinant protein expression.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20061120